Myocardin (Myocd) is a potent transcriptional coactivator that has been implicated in cardiovascular development and adaptation of the cardiovascular system to hemodynamic stress. To determine the function of myocardin in the developing cardiovascular system, Myocd F/F /Wnt1-Cre + and Myocd F/F /Pax3-Cre + mice were generated in which the myocardin gene was selectively ablated in neural crest-derived SMCs populating the cardiac outflow tract and great arteries. Both Myocd F/F /Wnt1-Cre + and Myocd F/F /Pax3-Cre + mutant mice survived to birth, but died prior to postnatal day 3 from patent ductus arteriosus (PDA). Neural crest-derived SMCs populating the ductus arteriosus (DA) and great arteries exhibited a cell autonomous block in expression of myocardin-regulated genes encoding SMC-restricted contractile proteins. Moreover, Myocd-deficient vascular SMCs populating the DA exhibited ultrastructural features generally associated with the SMC synthetic, rather than contractile, phenotype. Consistent with these findings, ablation of the Myocd gene in primary aortic SMCs harvested from Myocd conditional mutant mice caused a dramatic decrease in SMC contractile protein expression. Taken together, these data demonstrate that myocardin regulates expression of genes required for the contractile phenotype in neural crest-derived SMCs and provide new insights into the molecular and genetic programs that may underlie PDA.
Introduction
Congenital heart disease is the most common cause of infantile deaths from birth defects in the United States. One of the most common congenital heart defects, affecting approximately 1 in 2,000 live-born infants is patent ductus arteriosus (PDA) (1) . Most frequently observed in preterm infants, PDA is a condition generally responsive to treatment with cyclooxygenase inhibitors (2) . In full-term infants, environmental exposures and maternal infection predispose to PDA (3) (4) (5) . However, there is emerging evidence that PDA in full-term infants may frequently have a genetic basis (6, 7) . Familial PDA has been observed in Char syndrome, which is caused by a mutation in TFAP2B, encoding a helix-span-helix transcription factor expressed in the cardiac neural crest (8) (9) (10) . More recently, French and American kindreds have been identified with heritable PDA and thoracic aortic aneurysms caused by mutations in the smooth muscle myosin heavy chain gene (MYH11) (11) .
The ductus arteriosus (DA) is a muscular artery derived from the sixth left aortic arch artery. The DA directs blood flow from the pulmonary artery to the aorta, shunting blood away from the embryonic lungs. The pulmonary orifice of the DA is located immediately to the left of the bifurcation of the pulmonary trunk. The aortic end of the DA lies just beyond the origin of the left subclavian artery. PGE2, a potent vasodilatory prostaglandin, plays a critical role in maintaining the open status of the DA during fetal life (12) . Normally, the DA is occluded shortly after birth, establishing discrete pulmonary and systemic circulations. In humans DA closure actually begins in the second trimester of pregnancy, with formation of an intimal cushion composed of synthetic SMCs and abundant subendothelial extracellular matrix (ECM) (6, 13) . At birth, with expansion of the lungs, the abrupt increase in oxygen tension inhibits ductal SMC voltage-dependent potassium channels, leading to an influx of calcium and ductal constriction (14) (15) (16) (17) . This is accompanied by a rapid decline in the level of circulating PGE2. Following functional closure, the ductus is anatomically obliterated when ductal SMCs secrete ECM and undergo apoptosis, resulting in fibrosis and formation of the ligamentum arteriosus.
Myocardin is a remarkably potent transcriptional coactivator expressed exclusively in cardiomyocytes and SMCs (reviewed in refs. 18, 19) . The mouse myocardin gene (Myocd) encodes 2 protein isoforms, which are differentially expressed in cardiomyocytes and SMCs, respectively (20) . The Myocd gene is expressed as early as E7.75 in the cardiac crescent, and subsequently Myocd is expressed in the embryonic heart and visceral and vascular SMCs (21, 22) . Myocardin physically associates with the MADS box transcription factor serum response factor (SRF), activating a subset of genes implicated in cardiomyocyte and SMC differentiation (21) (22) (23) (24) . In ES cells, forced expression of myocardin transactivates most but not all genes encoding SMC contractile proteins (21) . Myocardin-null (Myocd -/-) mouse embryos survive only to embryonic day E10.5, precluding assessment of the function of myocardin in late fetal and postnatal development (25) . Myocd -/-embryos exhibit a block in vascular SMC differentiation as well as defects in the yolk sac vasculature (19, 25) . The primary cause of lethality in Myocd -/-embryos is the subject of ongoing investigations.
Myocardin is a member of a multigene family, which in metazoan species includes myocardin-related transcription factor-A (MRTF-A)/MKL1 and MRTF-B/MKL2 (reviewed in ref. 18) . As with myocardin expression, forced expression of MRTF-A and MRTF-B transactivates SRF-dependent transcriptional regulatory elements controlling expression of SMC contractile genes (26) . While all 3 MRTFs transduce cytoskeletal signals to the nucleus, it is noteworthy that myocardin is constitutively nuclear, while MRTF-A and MRTF-B translocate between the cytoplasm and the nucleus (27, 28) . Mice harboring null or hypomorphic mutations in MRTF-B exhibit a spectrum of cardiovascular patterning defects, recapitulating common forms of congenital heart disease observed in humans (29) (30) (31) . These patterning defects are attributable to a block in differentiation of cardiac neural crest cells into vascular SMCs. By contrast, MRTF-A mutant mice are viable, but exhibit defects in myoepithelial cell differentiation, resulting in a block in the lactation cycle (32) .
In the studies described in this report, the mouse Myocd gene was selectively ablated in the neural crest to examine the function of myocardin in vascular patterning and cardiovascular development. This conditional gene-targeting strategy isolates the function of myocardin in neural crest-derived SMCs from its function(s) in the heart and yolk sac vasculature. In contrast to myocardin-null mutants (Myocd -/-), which die prior to E10.5 (25) , mice harboring a neural crest-restricted deletion of the myocardin gene (Myocd F/F /Wnt1-Cre + and Myocd F/F /Pax3-Cre + ) are born in the anticipated Mendelian ratio, but die prior to P3 from PDA. At the molecular level, Myocd F/F /Wnt1-Cre + and Myocd F/F /Pax3-Cre + pups exhibit a cell autonomous defect in expression of myocardinregulated genes encoding SMC contractile proteins. These studies demonstrate that myocardin plays a critical role in differentiation of neural crest-derived SMCs populating the great arteries as well as maintenance of the contractile SMC phenotype. Moreover, these studies provide a conceptual framework for understanding the molecular pathogenesis of PDA.
Results

Generation of mice containing a conditional null mutation of myocardin.
To conditionally inactivate the Myocd gene, we created a modified allele in which exon 8, encoding the basic and the N terminus of the glutamine-rich domain of Myocd, is flanked by loxP (floxed) sites ( Figure 1A ). Exon 8 was targeted because the basic and glutamine-rich domains of myocardin are required for the association of myocardin with SRF and the capacity of myocardin to function as a transcriptional coactivator (22) . In addition, cryptic splicing around exon 8 generates an out-of-frame truncated myocardin mutant protein. Correctly targeted ES cell clones were identified by Southern blot analyses ( Figure 1B) . ES cells containing a conditional mutation in the myocardin gene (Myocd F/+ ) were injected into blastocysts to generate chimeric mice that transmitted the conditionally targeted Myocd allele through the germ line.
Homozygous myocardin floxed mice (Myocd F/F ) are viable, fertile, and generally indistinguishable from control littermates, demonstrating that the conditional gene-targeting strategy employed did not disrupt expression of the Myocd gene. To confirm that the gene-targeting strategy generated a true null allele, homozygous myocardin floxed mice (Myocd F/F ) were intercrossed with CMV-Cre transgenic mice that express high levels of Cre recombinase throughout the embryo (33 In order to determine the precise spatial and temporal pattern of Cre-mediated gene excision, Wnt1-Cre transgenic mice were interbred with R26R indicator mice that express β-galactosidase in cells following Cre-mediated recombination (35) . As anticipated, in P2 Wnt1-Cre + /R26R + mice, blue staining indicative of β-galactosidase activity was observed in arteries populated by neural crest-derived SMCs including the aorta (from the aortic root to the point of insertion of the DA), the internal carotid arteries (ICA), the proximal subclavian arteries (SC), and the DA ( Figure 2B ). By contrast, β-galactosidase activity was not observed in R26R + control mice ( Figure 2 , A and B). Of note, in the ascending aorta (AAo) and aortic arch, β-galactosidase activity is observed in most but not all of SMCs populating the tunica media ( Figure 2C ). Moreover, relatively few cells in the pulmonary artery express β-galactosidase, while almost all SMCs in the DA stained intensely blue ( Figure 2D ).
Wnt1-Cre-mediated recombination was observed beginning at E9.5 in neural crest-derived SMCs populating the cardiac outflow tract and branchial arch arteries (data not shown). At E11.5, 
Conditional deletion of myocardin in neural crest-derived VSMCs results in perinatal lethality. In contrast to myocardin-null mutant embry-
os, which survived only to E10.5 (25) , Myocd F/F /Wnt1-Cre + mutant pups were born in the anticipated Mendelian ratio (Table 1) . At birth Myocd F/F /Wnt1-Cre + pups were indistinguishable from control littermates. However, shortly after birth Myocd F/F /Wnt1-Cre + pups became cyanotic, and with rare exception mutant embryos died prior to P3. To confirm that neural crest-restricted deletion of myocardin was responsible for the observed phenotype, homozygous myocardin conditional mutant mice (Myocd F/F ) were intercrossed with Pax3-Cre transgenic mice, which also direct highly efficient Cre-mediated recombination in the neural crest (36) . Homozygous conditional mutant mice (Myocd F/F /Pax3-Cre + ) were born in the anticipated Mendelian ratio. However, once again, these conditionally targeted myocardin mutant mice died prior to P3 (data not shown).
Myocardin mutant mice exhibit PDA. MRTF-B mutant mice exhibit a spectrum of cardiovascular patterning defects attributable to a cell autonomous block in differentiation of the cardiac neural crest (29) (30) (31) . Given the conserved structure and overlapping patterns of expression of myocardin and MRTF-B in the developing embryo (18), we postulated that Myocd F/F /Wnt1-Cre + pups might exhibit common forms of congenital heart disease attributable to alterations in neural crest patterning of the cardiac outflow tract and great arteries. However, defects in patterning of the cardiac outflow tract and great arteries were not observed in 24 Myocd F/F /Wnt1-Cre + mutant mice examined at P2 (Figure 3, A and E) . However, intracardiac injection of toluidine blue revealed a widely PDA in all 24 Myocd F/F /Wnt1-Cre + mutants that were analyzed at P2 ( Figure 3E ). By contrast, the DA was occluded in each of the 22 control littermates analyzed at P2 ( Figure 3A) . Histological examination of the DA harvested from control and mutant mice at P2 revealed complete occlusion of the DA in control mice ( Figure 3 chain (SM-MyHC), and SM22α in medial SMCs (Figure 4 , B, D, F, and H) compared with control embryos (Figure 4 , A, C, E, and G). Consistent with these findings, expression of SMC contractile proteins was markedly diminished in the DA in Myocd F/F /Pax3-Cre + mutant mice (data not shown).
To confirm that the marked decrease in SMC contractile protein expression observed in the DA of Myocd F/F /Wnt1-Cre + mutant mice was attributable to neural crest-derived SMCs, Myocd F/+ /Wnt1-Cre + mice were bred into the R26R genetic background to generate Myocd F/F /Wnt1-Cre + /R26R + triple mutant mice. In triple mutant mice, cells undergoing Cre-mediated recombination express β-galactosidase (recognized as blue stain). As anticipated, Myocd F/F / Wnt1-Cre + /R26R + triple mutants died prior to P3, and all triple mutants exhibited PDA, and expression of SMC contractile proteins was markedly diminished in the DA of triple mutant mice (data not shown). Remarkably, essentially all SMCs populating the DA of the triple mutant mice stained intensely blue (Figure 4 , I and J) confirming that these cells are of neural crest origin and that myocardin-deficient neural crest cells migrate appropriately to the cardiac outflow tract and DA. Taken together, these data demonstrate that myocardin regulates expression of SMC contractile genes in neural crest-derived SMCs populating the DA.
Myocardin conditional mutant mice exhibit a generalized block in neural crest-derived SMC differentiation. The finding of severely diminished expression of SMC contractile proteins in the DA, raised the question of whether myocardin plays a unique role in regulating genes encoding SMC contractile proteins in the DA or whether this merely reflects a generalized defect in SMC differentiation in neural crest-derived SMCs. Immunohistochemical staining of the ascending aorta and aortic arch of Myocd F/F /Wnt1-Cre + mutant mice revealed markedly diminished expression of SMA, SM-MyHC, and SM22α ( Figure 5 , B, E, H, and K) compared with their control littermates ( Figure 5 , A, D, G, and J). As anticipated, robust levels of SMC contractile proteins were observed in the descending aorta of Myocd F/F /Wnt1-Cre + mutant mice, which is populated with SMCs arising from the lateral mesoderm ( Figure  5 , C, F, I, and L). Real-time RT-PCR performed on mRNA harvested from the proximal aorta (isolated from the aortic root to the insertion site of the DA) of 4 P2 myocardin conditional mutant mice (gray bars) and control pups (black bars) revealed 70%-80% decreases in expression of SMA, calponin-h1 (calponin), SM-MyHC, and SM22α mRNA, respectively, in Myocd F/F /Wnt1-Cre + mutant mice compared with control Myocd F/F mice ( Figure 5M ). These data demonstrate that myocardin regulates expression of genes encoding SMC contractile proteins in neural crest-derived SMCs populating the cardiac outflow tract and great arteries.
Myocardin-mediated regulation of SMC phenotype. Electron microscopic analysis of the DA in 3 P2 Myocd F/F /Wnt1-Cre + mutant pups and 3 control littermates revealed marked disruption of arterial architecture as well as profound changes in the phenotype of SMCs in the mutant mice ( Figure 6 ). At P2 the tunica media of the DA in control mice is composed of longitudinally and spirally arranged layers of SMCs within loose connective layers of elastic tissue (Figure 6 , A and C) (38) . By contrast, in Myocd F/F /Wnt1-Cre + mutant mice the architecture of the neointima and tunica media was markedly disturbed ( Figure 6, B and D) . In the mutant DA there was a dramatic increase in ECM and a relative loss of SMC volume ( Figure 6 , C and D). In the conditional mutant mice, SMC size was heterogeneous with a loss of spindle-like cell morphology. High-power magnification revealed relatively few myofibers (arrows) in mutant SMCs compared with control SMCs (Figure 6 , E and F). Surprisingly, there was also a marked increase in synthetic organelles including the rough endoplasmic reticulum (open arrows) and Golgi in Myocd F/F /Wnt1-Cre + mutants compared with control littermates ( Figure 6 , G and H). Nuclear membrane blebbing and/or nuclear condensation, indicative of apoptosis, were not observed in ductal SMCs of the myocardin mutant mice (data not shown). Consistent with this finding, no differences were observed in TUNEL-staining in the tunica media of the DA of Myocd F/F /Wnt1-Cre + mice and control littermates harvested from E12.5 to P2 (data not shown).
These data suggested that vascular SMCs in the DA of Myocd F/F / Wnt1-Cre + mutants assume a synthetic phenotype. To determine whether ECM proteins accumulate in the DA of P2 myocardin con- ditional mutant mice, sections of the DA were stained with antibodies that recognize fibronectin and laminin and visualized by confocal microscopy ( Figure 7) . A dramatic increase in fibronectin expression was observed in the DA of Myocd F/F /Wnt1-Cre + mutants compared with control mice (compare Figure 7, A and B) . In addition, a marked increase in expression of laminin was observed in the DA of myocardin conditional mutant mice ( Figure 7 , C and D). Taken together, these data demonstrate that myocardin regulates expression of contractile genes required for closure of the DA. Moreover, these data reveal that myocardin-deficient SMCs assume a synthetic phenotype manifested by changes in cellular morphology and a concomitant increase in synthetic organelles and ECM.
Myocardin regulates maintenance of the SMC contractile phenotype. To determine whether myocardin is required for maintenance of the differentiated SMC phenotype, primary cultures of mouse aortic SMCs harvested from myocardin conditional mutant mice (Myocd F/F ) were infected with Ad-Cre, a replication-defective adenovirus (RdAV) encoding Cre recombinase, or the control virus Ad-GFP, which encodes green fluorescent protein (GFP). The transduction efficiency of SMCs following RdAV infection was greater than 90% under the experimental conditions employed. Consistent with this finding, RT-PCR confirmed that myocardin mRNA decreased by 90% in SMC cultures infected with Ad-Cre relative to levels of myocardin gene expression observed in Ad-GFP-infected cells. Six days after infection, transduced SMCs were harvested and stained with antibodies that recognize Cre recombinase, SM-MyHC, calponin-h1, SM22α, and SMA, respectively. In aortic SMCs infected with the control virus Ad-GFP, colocalization of green staining with red staining, indicative of SM-MyHC expression, was observed (Figure 8, A-C) . By contrast, expression of SM-MyHC (red staining) was not observed in cells transduced with Ad-Cre (green stain) (Figure 8, D-F Ad-Cre virus. Of note, Myocd F/F SMCs transduced with the Ad-Cre were easily distinguished from nontransduced SMCs by their appearance, which was smaller and more polygonal.
To quantify expression of proteins in Myocd F/F SMCs transduced with Ad-Cre and Ad-GFP, respectively, Western blot analyses were performed with whole cell lysates prepared from the transduced SMCs. As anticipated, high levels of GFP were observed in cells transduced with Ad-GFP, while abundant Cre recombinase was detected in cells infected with Ad-Cre ( Figure 8S ). Consistent with the immunohistochemical analyses, expression of contractile proteins including SMA and SM22α was dramatically decreased in Myocd F/F SMCs transduced with Ad-Cre relative to levels observed in cells transduced with Ad-GFP. By contrast, expression of GAPDH was comparable in SMCs transduced with Ad-Cre and Ad-GFP. Taken together, these data demonstrate that myocardin is required for maintenance of contractile protein expression in vascular SMCs. Of note, the primary aortic SMCs utilized in these experiments are derived from the cardiac neural crest and lateral mesoderm.
Discussion
Transcriptional coactivators provide a flexible mechanism to expand information encoded within the genome in response to developmental and environmental stimuli (reviewed in ref. 18 ). Myocardin is a potent transcriptional coactivator expressed exclusively in cardiomyocytes and SMCs (22) . Myocardin physically associates with the MADS box transcription factor SRF, activating expression of a set of genes encoding SMC contractile proteins (reviewed in refs. 18, 19) . To determine the cell autonomous function(s) of myocardin in cardiac neural crest-derived SMCs that populate the cardiac outflow tract and great arteries, we generated and characterized mice in which the myocardin gene was selectively ablated in neural crest-derived SMCs. Myocd F/F /Wnt1-Cre + and Myocd F/F /Pax3-Cre + mice survive to birth, but die prior to P3 from complications related to PDA. A dramatic reduction in contractile proteins was observed in neural crest-derived SMCs populating the DA and great arteries of Myocd conditional mutant mice. Surprisingly, Myocd-deficient vascular SMCs also exhibited features associated with the synthetic SMC phenotype. Moreover, ablation of the Myocd gene in primary aortic SMCs harvested from conditionally gene-targeted mice led to a profound decrease in contractile SMC protein expression. Taken together, these data provide unequivocal evidence that myocardin regulates expression of genes encoding SMC proteins required for maintenance of the contractile SMC phenotype. In addition, these data provide new insights into the molecular and genetic programs underlying PDA.
Myocardin-null mutant mice survive only to E10.5, exhibiting defects in the embryonic and yolk sac vasculature, growth retardation, and developmental delay (25) . By contrast, Myocd F/F /Wnt1-Cre + and Myocd F/F /Pax3-Cre + mice survived to birth but died prior to P3 from complications related to PDA. What might account for these distinct phenotypes? As with most mice generated using conditional gene-targeting strategies, the phenotype of Myocd F/F /Wnt1-Cre + and Myocd F/F /Pax3-Cre + mutant mice represents a hypomorphic, as opposed to true null, phenotype. Low levels of myocardin expression were detectable in some SMCs populating the cardiac outflow tract, aorta, and great arteries (Figures 4 and 5) . Moreover, cell fate mapping studies have shown that some SMCs populating the ascending aorta are derived from the secondary or anterior heart field (39) . As such, these cells may play an important role in cardiac outflow tract patterning. However, we believe that the observed differences between Myocd-null embryos and Myocd F/F / Wnt1-Cre + and Myocd F/F /Pax3-Cre + pups is principally related to the neural crest-restricted conditional gene-targeting strategy employed in these experiments. Both the Wnt1 and Pax3 promoters efficiently target neural crest-derived SMCs populating the cardiac outflow tract and great arteries (34) . SMCs populating the extraembryonic or yolk sac vasculature are not neural crest-derived. As such, the Wnt1-Cre and Pax3-Cre gene-targeting lines utilized in these studies serve to distinguish the function(s) of myocardin in the embryonic vasculature from its function(s) in the extra-embryonic vasculature. Consistent with this, we have recently observed profound defects in the yolk sac vasculature and evidence of generalized intrauterine growth retardation in CMV-Cre + /Myocd F/F mutant embryos (J. Huang and M. Parmacek, unpublished observations). In addition, Olson and colleagues have reported defects in the yolk sac vasculature of myocardin-null embryos (19) .
The capacity of vascular SMCs to modulate their phenotype in response to vascular injury has been implicated in the pathogenesis of vascular proliferative syndromes, including atherosclerosis and restenosis following balloon angioplasty and/or intravascular stenting (reviewed in ref. 40 ). We and others have shown that myocardin functions as a transcriptional coactivator, directly activating transcription of genes encoding SMC contractile proteins (reviewed in ref. 18 ). Therefore, it was not surprising that in myocardin conditional mutant mice expression of SMC-restricted contractile proteins was dramatically downregulated in the DA and neural crest-derived great arteries. By contrast, the demonstration that myocardin-deficient SMCs in the intact vasculature assume a synthetic SMC phenotype was not anticipated (reviewed in ref. 40) . These data place myocardin at a critical nodal point required for maintenance of the contractile SMC phenotype. However, it remains unclear whether myocardin directly and/or indirectly suppresses the synthetic SMC phenotype. At a molecular level, these processes may be functionally coupled, at least in part, via direct competition for binding to SRF between myocardin and ternary complex factors (TCFs) in the Ets family (41) .
It remains unclear what mechanisms distinguish the functions of MRTFs in tissues where they are coexpressed. Genetically engineered mice harboring mutations in myocardin, MRTF-A and MRTF-B, respectively, exhibit distinct phenotypes (18) . Disruption of MRTF-B gene results in profound patterning defects of the cardiac outflow tract and great arteries recapitulating common forms of congenital heart disease (29) (30) (31) . Like the myocardin conditional mutant mice, the MRTF-B mutants demonstrated a marked decrease in expression of genes encoding SMC contractile proteins (29) (30) (31) . However, in contrast to the myocardin conditional mutants, MRTF-B mutant mice exhibit abnormal patterning of the branchial arch arteries as early as E11.0-11.5. In this regard it is noteworthy that MRTF-B is expressed as early as E8.0 in cardiac neural crest cells populating rhombomeres 3 and 5 (29) , while myocardin mRNA is not detected in the hindbrain of the unturned mouse embryo (J. Li and M. Parmacek, unpublished observations). Therefore, a developmental window exists between E8.0 and E9.5 when MRTF-B is expressed in the cardiac neural crest cells and myocardin is not. We postulate that expression of MRTF-B in cardiac neural crest cells during this critical window of time provides an instructive signal required for proper patterning of the branchial arch arteries that impacts on patterning of the aorta and great arteries. Alternatively, myocardin and MRTF-B may differentially respond to intracellular signals and/or activate distinct subsets of target genes. The precise molecular targets of MRTF-B and myocardin in the cardiac neural crest and neural crest-derived SMCs are the subject of ongoing investigation.
The demonstration that Myocd F/F /Wnt1-Cre + and Myocd F/F /Pax3-Cre + pups succumb to PDA in the perinatal period underscores the importance of the PDA in redirecting the fetal circulation required for postnatal survival. The DA has evolved unique anatomic and physiological properties required to regulate and direct the embryonic and postnatal circulations. The tunica media of the aorta and pulmonary artery are composed of circumferentially arranged layers of SMCs and elastic fibers. By contrast, the media of the DA is composed of longitudinally and spirally arranged layers of SMCs and a rich network of ECM and elastic fibers. After birth an increase in oxygen tension and decline in circulating PGE2 stimulates contraction of ductal SMCs required for functional separation of the pulmonary and systemic circulation (14) . As such, the observed PDA in myocardin mutant mice resulted from failure of ductal SMCs to effectively contract due to marked downregulation of SMC contractile proteins. Analysis of Myocd F/F /Wnt1-Cre + /R26R + triple mutant mice confirmed that virtually all SMCs populating the mutant DA are neural crest-derived, precluding the possibility of compensation from nonneural crest-derived SMCs in the DA. Of note, neural crest-derived cells also contribute to the aortic and pulmonary valves (AV and PV). However, the AV and PV valve of P2 Myocd F/F / Wnt1-Cre + /R26R + triple mutants appear morphologically normal, suggesting strongly that expression of myocardin in cardiac neural crest-derived cells is not required for embryonic development of the AV or PV (J. Huang and M. Parmacek, unpublished observations).
Increasing evidence suggests that multiple genes may predispose to PDA, possibly exacerbated by environmental triggers (7, 8, 11, 42, 43) . The demonstration that selective ablation of Myocd in cardiac neural crest-derived SMCs populating the DA gives rise to PDA suggests myocardin and/or myocardin-regulated genes may be involved in the pathogenesis of PDA. Consistent with this hypothesis, French and American kindreds have recently been described with heritable PDA and thoracic aortic aneurysm (11) . This syndrome is attributable to mutations in the smooth muscle myosin heavy chain gene (MYH11), a direct transcriptional target of myocardin (11) . Because myocardin-deficient mice with PDAs did not survive beyond P3, we
Figure 7
Accumulation of ECM protein in the DA of P2 Myocd F/F /Wnt1-Cre + mutant mice. Sections of the DA were stained with antibodies that recognize fibronectin (FN) and laminin and visualized by confocal microscopy. A dramatic increase in fibronectin expression was observed in the DA of Myocd F/F /Wnt1-Cre + mutants compared with control mice (compare A and B) . In addition, a marked increase in expression of laminin was observed in the DA of myocardin conditional mutant mice (compare C and D). Original magnification, ×200.
cannot determine whether over time they would develop thoracic aortic aneurysms and/or aortic dissections. However, the anatomic derangements observed with the mutant DA recapitulate many features observed in aortae of patients harboring MYH11 mutations. In any case, these data serve to identify Myocd and myocardin-regulated genes as candidate genes that may play a role in the pathogenesis of PDA and possibly diseases of the aorta.
Methods
Generation and characterization of mice with a conditional-targeted myocardin allele.
The conditional gene-targeting vector was constructed via recombineering with a BAC as described (44) . A BAC containing the Myocd gene (clone no. RP22-139L16) was isolated from the ARPCI-22 129 mouse BAC library. The homology arms used for subcloning and gene-targeting were PCR amplified from BAC DNA. Each arm was subcloned into the MC1TK-containing plasmid PL253 to generate a gap-repair plasmid. A mini-targeting vector was constructed and cloned into PL452 containing a floxed neomycin (Neo) selection cassette. The Neo cassette was excised with Cre recombinase, leaving a single loxP site at the targeted locus. An EcoRI restriction site was included in the mini-targeting vector to identify correctly targeted ES cells ( Figure 1A ). To assess whether the loxP and FRT sites remained intact in the targeting vector, the Myocd conditional gene-targeting vector plasmid DNA was transformed into arabinose-induced EL350 and EL250 cells, respectively. Targeted cells containing the plasmid were selected with ampicillin. Southern blot analyses were performed as described previously (45) . The Myocd conditional gene-targeting vector was linearized with NotI and electroporated into SV129-derived ES cells as described previously (45) . Transformants were selected in G418 and ganciclovir as described (45) . DNA from G418-resistant ES cell clones was analyzed by Southern blot analysis after EcoRI digestion with a radiolabeled probe derived from genomic sequences located 5′ of the targeting vector ( Figure 1A , black rectangle). The conditionally targeted allele generates an 11.4-kb hybridization signal (wildtype) and 9.4-kb (mutant) EcoRI fragment using a 5′ probe. One hundred and twenty colonies were obtained, and six colonies with the conditionally targeted Myocd allele were identified.
ES cell clones with selective Neo deletion were identified by Southern blot analysis ( Figure 1, A and B) . Correctly targeted cells were microinjected into C57BL/6 donor blastocysts as described previously (46) . The resulting male chimeras were mated with C57BL/6 females, and agouti offspring were genotyped by Southern blot analysis using EcoRI-digested DNA ( Figure 1A ).
Figure 8
Myocardin-regulated maintenance of the contractile SMC phenotype. Primary SMCs isolated from Myocd F/F aortae were infected with Ad-GFP (GFP) (A-C, G-I, and M-O) or Ad-Cre recombinase (Cre) (D-F, J-L, and P-R). Six days after infection, SMCs were immunostained with antibodies that recognize GFP, Cre, SMMyHC (B, C, E, and F), calponin-h1 (H, I, K, and L 
